胆固醇控制：FK 506免疫抑制下胰肾联合移植的长期益处。 - Suppr | 超能文献

Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression.

作者信息

Burke G W, Ciancio G, Alejandro R, Roth D, Ricordi C, Skyler J S, Tzakis A, Miller J

机构信息

University of Miami Medical Center, Department of Surgery, FL 33136, USA.

出版信息

Transplant Proc. 1998 Mar;30(2):513-4. doi: 10.1016/s0041-1345(97)01381-x.

DOI:10.1016/s0041-1345(97)01381-x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression.胆固醇控制：FK 506免疫抑制下胰肾联合移植的长期益处。

Transplant Proc. 1998 Mar;30(2):513-4. doi: 10.1016/s0041-1345(97)01381-x.

2

Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.肾胰联合移植中基于他克莫司与基于环孢素的免疫疗法对比

Transplant Proc. 1996 Apr;28(2):899.

3

Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy.同期胰肾联合移植与单独胰腺移植的等效成功率。一项采用他克莫司免疫抑制及经皮活检的前瞻性试验。

Ann Surg. 1996 Oct;224(4):440-9; discussion 449-52. doi: 10.1097/00000658-199610000-00003.

4

Can we improve the results of simultaneous pancreas-kidney transplantation?我们能否提高胰肾联合移植的效果？

Transplant Proc. 1998 Sep;30(6):2818-9. doi: 10.1016/s0041-1345(98)00824-0.

5

Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.他克莫司与环孢素微乳剂在初次同期胰肾联合移植中的疗效与安全性：一项大型多中心试验的1年结果

Transplantation. 2004 Apr 27;77(8):1221-8. doi: 10.1097/01.tp.0000120865.96360.df.

6

Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.在一项关于两种免疫抑制方案的前瞻性随机研究中，胰肾联合移植术后手术并发症谱。

Nephrol Dial Transplant. 2005 May;20 Suppl 2:ii54-62. doi: 10.1093/ndt/gfh1083.

7

Conversion of pancreas transplants to FK 506 from CsA.胰腺移植从环孢素A转换为他克莫司（FK 506）。

Transplant Proc. 1995 Dec;27(6):3032-3.

8

Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.他克莫司在胰腺移植中的应用：一项多中心分析。他克莫司胰腺移植研究组。

Clin Transplant. 1997 Aug;11(4):299-312.

9

Rejection after simultaneous pancreas-kidney transplantation.胰肾联合移植后的排斥反应。

Nephrol Dial Transplant. 2005 May;20 Suppl 2:ii11-7, ii62. doi: 10.1093/ndt/gfh1077.

10

Antibody induction therapy in pancreas transplantation.胰腺移植中的抗体诱导治疗。

Transplant Proc. 1998 Jun;30(4):1556-9. doi: 10.1016/s0041-1345(98)00356-x.

引用本文的文献

1

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.他克莫司在实体器官移植中的临床药代动力学与药效学

Clin Pharmacokinet. 2004;43(10):623-53. doi: 10.2165/00003088-200443100-00001.

2

Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.他克莫司：其在器官移植管理中的药理学及治疗应用的进一步更新

Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021.